Last checked at 7 Jul 2025 14:35
Sponsored Content
Don't want ads? Click here
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here
Don't want ads? Click here
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Sponsored Content
Duke Capital Share News (DUKE)
DUKE Share
Price
DUKE Share
News
DUKE Share
Chat
DUKE Share
Trades66
DUKE
Live RNS
DUKE Share
Charts
DUKE Level 2
Console
DUKE Live
Share Price
DUKE Broker
Ratings
DUKE Directors
Deals
DUKE Financial
Diary
DUKE
Fundamentals
DUKE Short
Positions
DUKE
Media
DUKE Company
Research
DUKE Company
Timeline
Duke Capital Information
Share Price Information for Duke Capital (DUKE)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
30.25
Bid:
30.00
Ask:
30.50
Change:
0.25 (0.83%)
Spread:
0.50 (1.667%)
Open:
30.00
High:
31.10
Low:
30.00
Prev. Close:
30.00
Last checked at -
Sponsored Content
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Timelines are a member only feature
Login to your account
Don't have an account? Click here to register.Duke Royalty agrees healthcare royalty financing deal with Marsh McLennan
Mon, 07th Sep 2015 12:28
(ShareCast News) - Royalty financing outfit Duke Royalty has signed an agreement with the consultancy arm of US insurance broking giant Marsh & McLennan to focus on healthcare royalty transactions in Europe.Oliver Wyman, a management consultancy arm of Marsh & McLennan, will offer royalty financing provided by Duke, which in June changed its name from Praetorian Resources and its investment strategy from natural resources to this newer alternative to debt financing.Duke's directors, which now include former Canaccord banker Neil Johnson as chief executive of Duke Royalty, bring expertise of the North American market for royalty financing, where companies pay back loans using a percentage of cash flow or revenue.The sector is worth around $30bn in North America but in Europe has yet to take off.Johnson said: "North America has built a number of highly successful and significant sized royalty companies in both the private and listed arenas. The Duke Royalty and Oliver Wyman collaboration will provide this progressive and compelling financing structure to the global healthcare industry."The collaboration would leverage Oliver Wyman's presence across 26 countries and with 200-plus professionals in its healthcare business, to initially focus on offering European healthcare companies a financing alternative via the US company's trusted name.Under the terms of the collaboration, Oliver Wyman will identify, analyse and assist in the acquisition of royalty interests for regulatory-approved, patent-protected ethical pharmaceutical and other healthcare products.Johnson said Duke looked forward to providing investors with "predictable revenues and a stable dividend".
More News
25 Jun 2025 11:58
EARNINGS: Real Estate Credit profit up; Duke Capital income drops
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more18 Jun 2025 14:47
2 Jun 2025 12:04
Duke Capital makes follow-on investment in Tristone Healthcare
(Sharecast News) - Duke Capital announced a £2.5m follow-on investment in Tristone Healthcare on Monday, comprising £2m in credit financing and £0.5m in equity, to support Tristone's acquisition of Serenity Care Homes.
Read more7 Apr 2025 14:11
2 Apr 2025 16:39
Duke Capital to fund investee New Path's latest acquisition
(Alliance News) - Duke Capital Ltd on Wednesday announced a follow-on investment of GBP3 million into existing capital partner New Path Fire & Security Ltd.
Read more20 Mar 2025 13:55
19 Feb 2025 15:17
Duke Capital makes £1.9m follow-on investment in BPVA Ireland
(Sharecast News) - Duke Capital announced a follow-on investment of £1.9m into BPVA Ireland on Wednesday, bringing its total investment in the company to £20.4m.
Read more7 Jan 2025 11:31
30 Dec 2024 17:36
London close: Stocks finish 2024's last full session weaker
(Sharecast News) - UK stocks closed slightly lower in subdued trading on Monday, with market activity reflecting the final full session of 2024 amid a lack of significant corporate news or economic developments.
Read more30 Dec 2024 10:32
Duke Capital expects quarterly revenue growth amid market uncertainty
(Alliance News) - Duke Capital Ltd on Monday said it expects steady revenue growth in the third quarter despite "uncertainty" in the market.
Read more30 Dec 2024 09:50
Duke Capital flags another rise in recurring cash revenue
(Sharecast News) - Hybrid business capital specialist Duke Capital said in a trading update on Monday that it anticipated recurring cash revenue of £6.5m for its third quarter, marking a 4% increase compared to £6.3m in the same period in the 2024 financial year.
Read more16 Dec 2024 20:12
IN BRIEF: Duke Capital profit and sales plunge, holds dividend
Duke Capital Ltd - Guernsey-based provider of capital solutions to small and medium-sized business owners in Europe and North America - Pretax profit plummets to GBP2.2 million in the six months to September 30 from GBP12.3 million a year prior. Total income more than halves to GBP10.3 million from GBP25.6 million. Recurring revenue totals GBP12.7 million, up 4.1% on GBP12.2 million. Dividend unchanged at 1.40 pence per share. Operating costs fall to GBP3.2 million from GBP4.9 million.
Read more16 Dec 2024 12:17
Duke Capital recurring cash revenue rises, total declines
(Sharecast News) - Duke Capital, a hybrid capital provider for small to medium enterprises in Europe and North America, reported a 4% year-on-year increase in recurring cash revenue to £12.7m in its interim results on Monday.
Read more26 Nov 2024 14:21
